State Department Cuts $60+ Billion in Wasteful Spending

Secretary Rubio has retained programs that met specific criteria and support U.S. interests. The State Department has saved $60 billion in taxpayer funding after thoroughly reviewing all grants…

Read More

HHS Secretary Launches Review of Childhood ADHD, Depression Medication

He claims that medications have been overprescribed. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. has made prescriptions for childhood chronic diseases, like attention-deficit/hyperactivity disorder…

Read More

FDA Approves First Treatment for Rare Disease

Ctexli offers hope for patients with a previously untreated metabolic disorder, Cerebrotendinous Xanthomatosis. The U.S. Food and Drug Administration (FDA) has approved Ctexli (chenodiol) as the first treatment…

Read More

Defense Secretary Realigns U.S. Military Focus to “One Force”

He implements the president’s executive order prohibiting transgender individuals in the military. Secretary of Defense Pete Hegseth sent a one-page memo to all military employees, directing them to…

Read More

Congressman Freezes During House Floor Speech

Representative Larson’s office states it is a side effect from a new medication. Congressman John Larson of Connecticut froze during a speech on the floor of the House…

Read More

Defense Department Applies AI Chatbots in Military Medicine Pilot

Chief Digital and Artificial Intelligence Office provides the latest report. The Department of Defense reported that its artificial intelligence (AI) office successfully concluded a pilot program that tested…

Read More

Federal Court Rules in Favor of Generic Drug Competition in Patent Case

The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…

Read More

FDA Approves Medication for Rare Adrenal Gland Disorder

Crenessity reduces glucocorticoid dependency and improves hormone control for classic CAH. The FDA has recently approved Crenessity (crinecerfont) for use alongside glucocorticoids in treating adults and children aged…

Read More

Medicare Proposal Expands Access to Care and Consumer Protections

CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…

Read More

Efforts Underway to Restore IV Fluid Supply in Hurricane Disruption of NC Facility

Federal agencies and Baxter International collaborate to boost IV fluid availability following severe storm damage. Hurricane Helene caused damage to Baxter International’s North Cove facility in North Carolina,…

Read More

Back to top
FE3